J&J Sales

Johnson & Johnson is a global healthcare leader that operates through two primary segments: Innovative Medicine (formerly Janssen) and Medical Technology (MedTech). The company focuses on high-impact therapeutic areas including oncology, immunology, neuroscience, cardiovascular, and pulmonary hypertension. Following the 2023 spin-off of its consumer health division, Kenvue, J&J has intensified its focus on pharmaceutical innovation and advanced medical devices. Its robust pipeline features diverse modalities such as CAR-T cell therapies, bispecific antibodies, and small molecules. The company is a major player in the oncology market with blockbuster drugs like Darzalex and Imbruvica, and it continues to expand its footprint in immunology with Tremfya and Stelara. J&J's MedTech division is a leader in surgery, orthopaedics, and interventional solutions, integrating digital and robotic technologies into clinical workflows.